Author: Khodadadi, Ehsaneh; Maroufi, Parham; Khodadadi, Ehsan; Esposito, Isabella; Ganbarov, Khudaverdi; Espsoito, Silvano; Yousefi, Mehdi; Zeinalzadeh, Elham; Kafil, Hossein Samadi
Title: Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19) Cord-id: hlw3t2rb Document date: 2020_5_5
ID: hlw3t2rb
Snippet: The recent epidemic outbreak of a novel human coronavirus called SARS-CoV-2 and causing the respiratory tract disease COVID-19 has reached worldwide resonance and a global effort is being undertaken to characterize the molecular features and evolutionary origins of this virus. Therefore, rapid and accurate identification of pathogenic viruses plays a vital role in selecting appropriate treatments, saving people's lives and preventing epidemics. Additionally, general treatments, coronavirus-speci
Document: The recent epidemic outbreak of a novel human coronavirus called SARS-CoV-2 and causing the respiratory tract disease COVID-19 has reached worldwide resonance and a global effort is being undertaken to characterize the molecular features and evolutionary origins of this virus. Therefore, rapid and accurate identification of pathogenic viruses plays a vital role in selecting appropriate treatments, saving people's lives and preventing epidemics. Additionally, general treatments, coronavirus-specific treatments, and antiviral treatments useful in fighting COVID-19 are addressed. This review sets out to shed light on the SARS-CoV-2 and host receptor recognition, a crucial factor for successful virus infection and taking immune-informatics approaches to identify B- and T-cell epitopes for surface glycoprotein of SARS-CoV-2. A variety of improved or new approaches also have been developed. It is anticipated that this will assist researchers and clinicians in developing better techniques for timely and effective detection of coronavirus infection. Moreover, the genomic sequence of the virus responsible for COVID-19, as well as the experimentally determined three-dimensional structure of the Main protease (Mpro) is available. The reported structure of the target Mpro was described in this review to identify potential drugs for COVID-19 using virtual high throughput screening.
Search related documents:
Co phrase search for related documents- active site and acute respiratory distress syndrome: 1, 2
- active site and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active site and addition viral infection: 1
- active site and additional function: 1
- active site and low concentration: 1, 2
- active site and low molecular weight: 1, 2, 3, 4
- acute kidney injury and additional function: 1, 2
- acute kidney injury and low concentration: 1, 2, 3
- acute kidney injury and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute respiratory distress syndrome and addition viral infection: 1, 2
- acute respiratory distress syndrome and additional function: 1
- acute respiratory distress syndrome and low concentration: 1
- acute respiratory distress syndrome and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- acute respiratory distress syndrome and low molecular weight heparin prophylactic: 1
- acute sars cov respiratory syndrome coronavirus and addition viral infection: 1, 2, 3, 4, 5, 6
- acute sars cov respiratory syndrome coronavirus and additional function: 1, 2, 3, 4, 5, 6
- acute sars cov respiratory syndrome coronavirus and liver cholangiocyte: 1
- acute sars cov respiratory syndrome coronavirus and low concentration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute sars cov respiratory syndrome coronavirus and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date